Penetrium Bioscience Inc. Q3 revenue KRW 1.9 billion, operating loss KRW 2.7 billion
AI summary · Not investment advice
Penitrium Bio sold KRW 1.9 billion worth in Q3 and lost KRW 2.7 billion from its main business, versus a KRW 1.5 billion loss a year earlier.
Operating profit · 3 months
KRW -2.7 billion
Key facts
- Revenue (3 months)
- KRW 1.9 billion
- Net income (3 months)
- KRW -2.7 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 2.6 billion
- Revenue (year to date)
- KRW 5.7 billion
- Operating profit (prior-year 3 months)
- KRW -1.5 billion
- Operating profit (year to date)
- KRW -6.4 billion
- Net income (prior-year 3 months)
- KRW -8.5 billion
- Net income (year to date)
- KRW -6.1 billion
Commentary
AI commentary · Not investment advice
What happened
Penitrium Bio reported its third-quarter results on a standalone basis. Sales for the three months were KRW 1.89 billion. That is 27.4% lower than the same period a year earlier. It is also 10.6% lower than the previous quarter. Cumulative sales this year are KRW 5.70 billion.
In the company's terms
Operating profit (profit from the core business) for the three months was a loss of KRW 2.67 billion. A year earlier, the same period showed an operating loss of KRW 1.46 billion. The cumulative operating loss this year is KRW 6.37 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the three months was a loss of KRW 2.74 billion. A year earlier, the same period showed a net loss of KRW 8.46 billion. The cumulative net loss this year is KRW 6.11 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
P